Biomedical and Biotechnology Research Journal (BBRJ)

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 4  |  Issue : 2  |  Page : 143--147

Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative


Prasanta Kumar Das, Somtirtha B Ganguly 
 State TB Demonstration Cum Training Centre, Intermediate Reference Laboratory, Kolkata, West Bengal, India

Correspondence Address:
Dr. Prasanta Kumar Das
State TB Demonstration Cum Training Centre, Intermediate Reference Laboratory, 2nd Floor, Dr. B. C. Roy Post Graduate Institute of Paediatric Sciences, 38, Badan Roy Lane, Kolkata 10, West Bengal
India

Background: Shorter multidrug-resistant (MDR) regimen has proved to be very effective in some of the developing nations such as Bangladesh and several African countries. Various shortcomings in the execution of long-term MDR regimen have prompted for adapting the shorter regimen in India. The study explored the experience of the programmatic management of tuberculosis by a shorter regimen in West Bengal, India. Materials and Methods: Retrospective analysis of the data included the outcome analysis of the cured, lost to followup, treatment completed, treatment failure, treatment regimen changed and died. These attributes were analyzed. Results: Of the total 203 cases, cure rate accounted for 44.3%. Lost to follow-up was found to be 13.7%, in which alternative dispute resolution accounted for the major cause. A substantial amount of INH resistance is seen among the follow-up culture positive cases speculating the role of ethionamide in the regimen.


How to cite this article:
Das PK, Ganguly SB. Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative.Biomed Biotechnol Res J 2020;4:143-147


How to cite this URL:
Das PK, Ganguly SB. Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative. Biomed Biotechnol Res J [serial online] 2020 [cited 2021 Dec 7 ];4:143-147
Available from: https://www.bmbtrj.org/article.asp?issn=2588-9834;year=2020;volume=4;issue=2;spage=143;epage=147;aulast=Das;type=0